World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
13450
World Ranking
3418
National Ranking
137

Overview

Masayuki Saijo is affiliated with the National Institute of Infectious Diseases in Tokyo, Japan. Their research primarily focuses on the field of Medicine, with a particular emphasis on Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology, Ecology, Evolution, Behavior and Systematics, and Global and Planetary Change.

The subfields of study that define Saijo's work include:

  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • Epidemiology
  • Ecology, Evolution, Behavior and Systematics
  • Global and Planetary Change

Main topics covered in Saijo's publications reflect a focus on viral infections and their vectors, outbreaks, and broader ecological impacts:

  • Viral Infections and Vectors
  • Viral Infections and Outbreaks Research
  • Mosquito-borne diseases and control
  • Vector-Borne Animal Diseases
  • Fire effects on ecosystems
  • SARS-CoV-2 and COVID-19 Research
  • Virology and Viral Diseases

Saijo's frequent publication venues include journals specializing in infectious diseases and virology. The most common venues are:

  • Viruses
  • PLoS Neglected Tropical Diseases
  • Emerging Infectious Diseases
  • Journal of Infection and Chemotherapy
  • Japanese Journal of Infectious Diseases

Frequent collaborators in Saijo's research work include the following coauthors:

  • Masayuki Shimojima (46 publications)
  • Tomoki Yoshikawa (43 publications)
  • Takeshi Kurosu (35 publications)
  • Shuetsu Fukushi (30 publications)
  • Tadaki Suzuki (25 publications)

Representative recent papers authored by Saijo cover topics ranging from antiviral drug research to epidemiologic studies of severe fever with thrombocytopenia syndrome (SFTS) and COVID-19 therapy:

  • "A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19," 2020, Antimicrobial Agents and Chemotherapy
  • "Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment," 2021, iScience
  • "Severe Fever with Thrombocytopenia Syndrome, Japan, 2013-2017," 2020, Emerging Infectious Diseases
  • "Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections," 2020, Journal of Clinical Investigation
  • "Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection," 2020, Frontiers in Microbiology

Best Publications

  • The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan

    Toru Takahashi;Ken Maeda;Tadaki Suzuki;Aki Ishido

  • A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.

    Yohei Doi;Masaya Hibino;Ryota Hase;Michiko Yamamoto

  • Sensitive and Specific PCR Systems for Detection of Both Chinese and Japanese Severe Fever with Thrombocytopenia Syndrome Virus Strains and Prediction of Patient Survival Based on Viral Load

    Tomoki Yoshikawa;Shuetsu Fukushi;Hideki Tani;Aiko Fukuma

  • Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells

    Tetsuya Mizutani;Shuetsu Fukushi;Masayuki Saijo;Ichiro Kurane

  • Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.

    Shuetsu Fukushi;Tetsuya Mizutani;Masayuki Saijo;Shutoku Matsuyama

  • Animal models for Ebola and Marburg virus infections.

    Eri Nakayama;Masayuki Saijo

  • Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013-2014.

    Hirofumi Kato;Hirofumi Kato;Takuya Yamagishi;Tomoe Shimada;Tamano Matsui

  • Severe Fever with Thrombocytopenia Syndrome, Japan, 2013-2017.

    Yusuke Kobayashi;Hirofumi Kato;Takuya Yamagishi;Tomoe Shimada

  • Phylogenetic and Geographic Relationships of Severe Fever With Thrombocytopenia Syndrome Virus in China, South Korea, and Japan

    Tomoki Yoshikawa;Masayuki Shimojima;Shuetsu Fukushi;Hideki Tani

  • Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus

    Hideki Tani;Aiko Fukuma;Shuetsu Fukushi;Satoshi Taniguchi

  • Lethal Canine Distemper Virus Outbreak in Cynomolgus Monkeys in Japan in 2008

    Kouji Sakai;Noriyo Nagata;Yasushi Ami;Fumio Seki

  • Potential anti-COVID-19 agents, Cepharanthine and Nelfinavir, and their usage for combination treatment.

    Hirofumi Ohashi;Hirofumi Ohashi;Koichi Watashi;Wakana Saso;Wakana Saso;Kaho Shionoya;Kaho Shionoya

  • Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever

    Andrea Marzi;Reiko Yoshida;Hiroko Miyamoto;Mari Ishijima

  • LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from Monkeypox

    Masayuki Saijo;Yasushi Ami;Yuriko Suzaki;Noriyo Nagata

  • Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes.

    Masahiro Niikura;Shiki Takamura;Gisen Kim;Satoru Kawai

  • Enzyme-Linked Immunosorbent Assay for Detection of Filovirus Species-Specific Antibodies

    Eri Nakayama;Ayaka Yokoyama;Hiroko Miyamoto;Manabu Igarashi

  • Reston Ebolavirus antibodies in bats, the Philippines.

    Satoshi Taniguchi;Satoshi Taniguchi;Shumpei Watanabe;Shumpei Watanabe;Joseph S. Masangkay;Tsutomu Omatsu

  • Recombinant Nucleoprotein-Based Enzyme-Linked Immunosorbent Assay for Detection of Immunoglobulin G Antibodies to Crimean-Congo Hemorrhagic Fever Virus

    Masayuki Saijo;Tang Qing;Masahiro Niikura;Akihiko Maeda

  • An Attenuated LC16m8 Smallpox Vaccine: Analysis of Full-Genome Sequence and Induction of Immune Protection

    Shigeru Morikawa;Tokuki Sakiyama;Hideki Hasegawa;Masayuki Saijo

  • JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells

    Tetsuya Mizutani;Shuetsu Fukushi;Masayuki Saijo;Ichiro Kurane

  • Immunofluorescence Technique Using HeLa Cells Expressing Recombinant Nucleoprotein for Detection of Immunoglobulin G Antibodies to Crimean-Congo Hemorrhagic Fever Virus

    Masayuki Saijo;Tang Qing;Masahiro Niikura;Akihiko Maeda

  • Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice.

    Noriyo Nagata;Naoko Iwata;Hideki Hasegawa;Shuetsu Fukushi

  • Detection of Ebola Viral Antigen by Enzyme-Linked Immunosorbent Assay Using a Novel Monoclonal Antibody to Nucleoprotein

    Masahiro Niikura;Tetsuro Ikegami;Masayuki Saijo;Ichiro Kurane

  • Severe Fever With Thrombocytopenia Syndrome Virus Targets B Cells in Lethal Human Infections

    Tadaki Suzuki;Yuko Sato;Kaori Sano;Takeshi Arashiro

Frequent Co-Authors

Shigeru Morikawa
Shigeru Morikawa National Institutes of Health
Ichiro Kurane
Ichiro Kurane National Institutes of Health
Masayuki Shimojima
Masayuki Shimojima National Institutes of Health
Tetsuya Mizutani
Tetsuya Mizutani Tokyo University of Agriculture and Technology
Noriyo Nagata
Noriyo Nagata National Institutes of Health
Hideki Hasegawa
Hideki Hasegawa National Institutes of Health
Tadaki Suzuki
Tadaki Suzuki National Institutes of Health
Tetsutaro Sata
Tetsutaro Sata National Institute of Infectious Diseases
Kazunori Oishi
Kazunori Oishi National Institutes of Health
Hideki Hasegawa
Hideki Hasegawa Hokkaido University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, complementary healthcare degrees often provide broader career opportunities. Those seeking clinical roles might explore programs such as Licensed Practical Nurse (LPN), which typically feature open access and are known for their easy admission LPN programs. These pathways offer a solid foundation in patient care and biomedical knowledge.

Advancing from nursing roles to specialized care, many consider which nurse practitioner program is easiest to enter, balancing quality education with pragmatic admission standards. Exploring which nurse practitioner program is easiest can optimize one’s route into advanced practice nursing, closely related to immunological healthcare applications.

For those drawn to mental health, psychiatric nurse practitioner specialization combines immunology with psychiatric sciences. To ensure hands-on experience, students should consult the best psychiatric mental health nurse practitioner programs online, known for strong clinical placement support and outcomes.

Cost efficiency remains a significant factor in choosing programs. Prospective students might explore affordable options by reviewing the cheapest pmhnp programs online. Combining affordability with quality prepares graduates for sustainable careers in immunology-related healthcare fields.

Best Scientists Citing Masayuki Saijo

Trending Scientists

Recently Published Articles